Carcinogenic Potential of Duodenal Reflux Juice from Patients with Long-standing Postgastrectomy
Overview
Affiliations
Aim: To determine whether study on the carcinogenic potential of reflux juice from patients with remote gastrectomy could clarify the inherent relationship between duodenal reflux and gastric stump cancer.
Methods: A total of 37 reflux juice samples (13 Billroth I, 24 Billroth II) were employed in the present study. A two-stage transformation assay using BALB/c 3T3 cells was carried out to test the initiating or promoting activity of these samples.
Results: Two of 18 (11.1%) reflux samples exerted initiating activities, whereas 9/19 (47.4%) samples enhanced the MNNG-initiating cell transformation, suggesting the duodenal reflux juice might more frequently possess the tumor-promoter activity (P = 0.029). In addition, there was no difference in initiating activities of the samples irrespective of surgical procedures (P = 0.488), while Billroth II samples exhibited stronger tumor-promoter activity than Billroth I samples (P = 0.027). Furthermore, the promoter activities were well correlated with the histological changes of the stomas (r(s) = 0.625, P = 0.004), but neither their cytotoxicities nor initiating activities had this correlation (Probabilities were 0.523 and 0.085, respectively).
Conclusion: The duodenal reflux juice from patients with remote postgastrectomy did have carcinogenic potential, and suggested that tumor-promoting activity should principally account for the high incidence of gastric cancer in gastrectomy patients. In contrast, it is difficult to explain the high stump-cancer incidence with the N-nitroso compounds theory-a popular theory for the intact stomach carcinogenesis, and it seemed to be justified to focus chemo-prevention of this cancer on the tumor-promoting potential of reflux juice.
Saeidi H, Nasiri M, Shahidsales S, Kermani A, Hematti S, Roodbari S Adv Biomed Res. 2015; 4:177.
PMID: 26605216 PMC: 4617152. DOI: 10.4103/2277-9175.164013.
Association of laryngeal cancer with previous gastric resection.
Cammarota G, Galli J, Cianci R, De Corso E, Pasceri V, Palli D Ann Surg. 2004; 240(5):817-24.
PMID: 15492563 PMC: 1356487. DOI: 10.1097/01.sla.0000143244.76135.ca.
Expression of estrogen receptor and estrogen receptor messenger RNA in gastric carcinoma tissues.
Zhao X, Gu S, Liu S, Pan B World J Gastroenterol. 2003; 9(4):665-9.
PMID: 12679906 PMC: 4611424. DOI: 10.3748/wjg.v9.i4.665.